1. Home
  2. ELOG vs GDTC Comparison

ELOG vs GDTC Comparison

Compare ELOG & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$0.81

Market Cap

10.5M

Sector

Industrials

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.82

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
GDTC
Founded
2006
2018
Country
China
Singapore
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
10.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ELOG
GDTC
Price
$0.81
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.5K
43.0K
Earning Date
07-17-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.68
52 Week High
$3.07
$3.68

Technical Indicators

Market Signals
Indicator
ELOG
GDTC
Relative Strength Index (RSI) 37.40 35.19
Support Level N/A $0.71
Resistance Level $1.00 $1.12
Average True Range (ATR) 0.07 0.11
MACD -0.01 -0.01
Stochastic Oscillator 0.00 21.06

Price Performance

Historical Comparison
ELOG
GDTC

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: